ASTRO 2020: Neoadjuvant Temozolomide and Radiotherapy Incorporating Metformin Appears Feasible and Safe for Treating Glioblastoma
Phase II data indicates the regimen is particularly effective in patients with methylated MGMGT gene promoter
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.